TY  - JOUR

T1  - Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers

JO  - npj Precision Oncology

UR  - https://doi.org/10.1038/s41698-024-00615-9

PY  - 2024/05/31

AU  - Nussbaum DP

AU  - Martz CA

AU  - Waters AM

AU  - Barrera A

AU  - Liu A

AU  - Rutter JC

AU  - Cerda-Smith CG

AU  - Stewart AE

AU  - Wu C

AU  - Cakir M

AU  - Levandowski CB et al

ED  - 

DO  - DOI: 10.1038/s41698-024-00615-9

PB  - Springer Science and Business Media LLC

VL  - 8

IS  - 1

Y2  - 2026/03/17

ER  -